State Street
MIRA icon

State Street’s MIRA Pharmaceuticals MIRA Stock Holding History

State Street’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.5K Hold
49,100
– – ﹤0.01% 4124
2025
Q4 		$74.1K Hold
49,100
– – ﹤0.01% 4098
2025
Q3 		$66.8K Hold
49,100
– – ﹤0.01% 4116
2025
Q2 		$59.4K Hold
49,100
– – ﹤0.01% 4068
2025
Q1 		$48.1K Hold
49,100
– – ﹤0.01% 4103
2024
Q4 		$56K Buy
+49,100
New +$64.1K ﹤0.01% 4091

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State Street's MIRA Position: Q1 2026 in Review

State Street held its MIRA Pharmaceuticals (MIRA) position steady in Q1 2026 at 49,100 shares worth $52.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4124.

State Street first reported a position in MIRA in Q4 2024 and has held it in 6 quarters since. The position peaked at $74.1K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • State Street held 49,100 shares of MIRA Pharmaceuticals worth $52.5K as of Q1 2026.
  • State Street left its MIRA Pharmaceuticals share count unchanged in Q1 2026.
  • MIRA Pharmaceuticals made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4124 holding.
  • State Street first reported a position in MIRA Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • State Street's MIRA Pharmaceuticals position peaked at $74.1K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.